Skip to main content
Frontiers in Pharmacology logoLink to Frontiers in Pharmacology
. 2024 Apr 18;15:1363218. doi: 10.3389/fphar.2024.1363218

Corrigendum: Sesquiterpene lactones attenuate paclitaxel resistance via inhibiting MALAT1/STAT3/ FUT4 axis and P-Glycoprotein transporters in lung cancer cells

Yaming Ding 1, Zhang Zhen 2, Muhammad Azhar Nisar 2, Farman Ali 3, Riaz Ud Din 2, Muhammad Khan 4, Tafail Akbar Mughal 5, Gulzar Alam 6, Linlin Liu 1,*, Muhammad Zubair Saleem 2,7,*
PMCID: PMC11063791  PMID: 38698815

In the published article, there was an error in Figures 5B,C as published. The striatum of Figures 5B,C in the article was not the final version. This may have been caused by an initial error in the image layout editing process. The molecular docking presentation in Figure 5B is duplicate of Figure 5A while Figure 5C is pasted incorrectly, however, the description of Figure 5 in the article is correct. The corrected Figure 5 and its caption appear below.

FIGURE 5.

FIGURE 5

Molecular docking of ALT and Brv-A to determine their binding affinities with FUT4, and P-GP. (A, B) Molecular docking of ALT and Brv-A with FUT4. (C, D) Molecular docking of ALT and Brv-A with P-GP.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.


Articles from Frontiers in Pharmacology are provided here courtesy of Frontiers Media SA

RESOURCES